Alpha 2.0
Login Register
» Authors » Maria Sfakianaki

Maria Sfakianaki

Explore the profile of Maria Sfakianaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 340
Followers 0
Related Specialties
Oncology
General Medicine
Science
Top 10 Co-Authors
John Souglakos
Ippokratis Messaritakis
Maria Tzardi
Dimitrios Mavroudis
Chara Papadaki
Maria Trypaki
Vassilis Georgoulias
John Tsiaoussis
Asimina Koulouridi
Nikolaos Gouvas
Published In
Cancers (Basel)
PLoS One
NDT Plus
J Photochem Photobiol B
Clin Cancer Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Case report: a rare case of diffusely metastatic V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland
Boukouris A, Kokkinakis I, Drakos E, Sfakianaki M, Tzardi M, Mavroudis D, et al.
Front Oncol . 2025 Feb; 15:1512000. PMID: 39935827
Metastastic disease affects up to 50% of colorectal cancer (CRC) patients and is associated with particularly poor outcomes in the presence of the V600E mutation. Herein, we report a patient...
2.
Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns
Fountzilas E, Papadopoulos T, Papadopoulou E, Gouedard C, Kourea H, Constantoulakis P, et al.
Diagnostics (Basel) . 2024 Jun; 14(11). PMID: 38893603
Determination of microsatellite instability (MSI)/mismatch repair (MMR) status in cancer has several clinical implications. Our aim was to integrate MSI/MMR status from patients tested in Greece to assess the prevalence...
3.
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis
Messaritakis I, Koulouris A, Boukla E, Vogiatzoglou K, Lagkouvardos I, Intze E, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38792001
Background: Colorectal cancer (CRC) significantly contributes to cancer-related mortality, necessitating the exploration of prognostic factors beyond TNM staging. This study investigates the composition of the gut microbiome and microbial DNA...
4.
LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer
Lagoudaki E, Koutsopoulos A, Sfakianaki M, Papadaki C, Manikis G, Voutsina A, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38791897
To investigate the incidence and prognostically significant correlations and cooperations of LKB1 loss of expression in non-small cell lung cancer (NSCLC), surgical specimens from 188 metastatic and 60 non-metastatic operable...
5.
Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study
Messaritakis I, Psaroudaki E, Vogiatzoglou K, Sfakianaki M, Topalis P, Iliopoulos I, et al.
Cancers (Basel) . 2023 Oct; 15(19). PMID: 37835512
Background: This study aimed to investigate the molecular profiles of 237 stage III CRC patients from the international IDEA study. It also sought to correlate these profiles with Toll-like and...
6.
Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations
Sfakianaki M, Tzardi M, Tsantaki K, Koutoulaki C, Messaritakis I, Datseri G, et al.
Cancers (Basel) . 2023 Jan; 15(2). PMID: 36672302
MMR gene germline mutations are considered a major genetic disorder in patients with hereditary nonpolyposis colon cancer (HNPCC) or Lynch syndrome; A total of 15% of sporadic colon carcinomas are...
7.
Investigation of Microbial Translocation, and Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients
Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, et al.
Cancers (Basel) . 2022 Sep; 14(18). PMID: 36139567
Gut microbial dysbiosis and microbial passage into the peripheral blood leads to colorectal cancer (CRC) and disease progression. Toll-like () and vitamin D () receptors play important role in the...
8.
Prognostic Value of Mutations in Colorectal Cancer Patients
Koulouridi A, Karagianni M, Messaritakis I, Sfakianaki M, Voutsina A, Trypaki M, et al.
Cancers (Basel) . 2022 Jul; 14(14). PMID: 35884381
Colorectal cancer (CRC) remains a major public health issue. The detection of parameters that affect CRC prognosis is of great significance. mutations, play a crucial role in tumorigenesis with a...
9.
Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment
Koulouridi A, Messaritakis I, Theodorakis E, Chondrozoumaki M, Sfakianaki M, Gouvas N, et al.
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298766
Oxaliplatin-fluoropyrimidine combination therapy is the gold standard treatment for patients with stage III colorectal cancer (CRC); however, treatment duration is now under re-evaluation. The aim of the study was the...
10.
Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies
Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, et al.
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298740
Metastatic colorectal cancer (mCRC) remains a highly lethal malignancy, although considerable progress has resulted from molecular alterations in guiding optimal use of available treatments. CRC recurrence remains a great barrier...